S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Landos Biopharma (LABP) News Today

$21.76
+0.09 (+0.42%)
(As of 04/18/2024 ET)
SourceHeadline
msn.com logoLandos Biopharma (LABP) Price Target Increased by 154.20% to 12.96
msn.com - April 17 at 10:47 AM
prnewswire.com logoStockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
prnewswire.com - April 16 at 3:32 PM
marketbeat.com logoLandos Biopharma, Inc. (NASDAQ:LABP) Short Interest Update
marketbeat.com - April 10 at 6:50 PM
marketbeat.com logoLandos Biopharma, Inc. Expected to Earn Q1 2024 Earnings of ($0.88) Per Share (NASDAQ:LABP)
marketbeat.com - April 3 at 6:00 AM
marketbeat.com logoHC Wainwright Reiterates Neutral Rating for Landos Biopharma (NASDAQ:LABP)
marketbeat.com - April 1 at 8:30 AM
businesswire.com logoLANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
businesswire.com - March 27 at 6:04 PM
finanznachrichten.de logoLandos Biopharma, Inc.: AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
finanznachrichten.de - March 27 at 7:38 AM
markets.businessinsider.com logoLeerink Partners Remains a Hold on Landos Biopharma (LABP)
markets.businessinsider.com - March 27 at 7:38 AM
prnewswire.com logoSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP
prnewswire.com - March 26 at 7:47 PM
markets.businessinsider.com logoAbbVie To Acquire Landos Biopharma At $20.42/share In Cash
markets.businessinsider.com - March 26 at 3:06 AM
bizjournals.com logoAbbVie to buy Landos Biopharma for $137 million
bizjournals.com - March 26 at 3:06 AM
finance.yahoo.com logoWhy Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
finance.yahoo.com - March 26 at 3:06 AM
investorplace.com logoWhy Is Landos Biopharma (LABP) Stock Up 168% Today?
investorplace.com - March 25 at 12:17 PM
prnewswire.com logoShareholder Alert: Ademi LLP investigates whether Landos Biopharma, Inc. has obtained a Fair Price in its transaction with AbbVie
prnewswire.com - March 25 at 12:03 PM
businesswire.com logoLABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders
businesswire.com - March 25 at 11:36 AM
reuters.com logoAbbVie to buy Landos to expand pipeline of immunity-related illnesses
reuters.com - March 25 at 8:39 AM
prnewswire.com logoAbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
prnewswire.com - March 25 at 8:31 AM
marketbeat.com logo
marketbeat.com - March 25 at 8:30 AM
globenewswire.com logoAbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
globenewswire.com - March 25 at 8:30 AM
investorplace.com logoLABP Stock Earnings: Landos Biopharma Misses EPS for Q4 2023
investorplace.com - March 21 at 2:05 PM
finanznachrichten.de logoLandos Biopharma, Inc.: Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
finanznachrichten.de - March 21 at 11:34 AM
benzinga.com logoRecap: Landos Biopharma Q4 Earnings
benzinga.com - March 21 at 11:34 AM
globenewswire.com logoLandos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
globenewswire.com - March 21 at 8:00 AM
benzinga.com logoXontogeny, LLC's Net Worth
benzinga.com - March 6 at 5:33 PM
finance.yahoo.com logoWill Landos Biopharma (NASDAQ:LABP) Spend Its Cash Wisely?
finance.yahoo.com - March 5 at 7:58 AM
benzinga.com logoAmbrx Biopharma Stock (NASDAQ:AMAM) Dividends: History, Yield and Dates
benzinga.com - January 10 at 3:44 PM
finance.yahoo.com logoLandos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
finance.yahoo.com - January 8 at 10:06 AM
msn.com logoLandos’s NX-13 shows symptom relief in Phase Ib ulcerative colitis trial
msn.com - November 22 at 3:15 PM
finanznachrichten.de logoLandos Biopharma, Inc.: Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn's and Colitis
finanznachrichten.de - November 21 at 1:25 PM
marketwatch.com logoLandos Biopharma Shares Rise 10% After Positive Trial Data for NX-13
marketwatch.com - November 21 at 1:25 PM
finance.yahoo.com logoLandos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitis
finance.yahoo.com - November 21 at 8:25 AM
msn.com logoLandos Biopharma GAAP EPS of -$0.94
msn.com - November 9 at 4:33 PM
benzinga.com logoLandos Biopharma: Q3 Earnings Insights
benzinga.com - November 9 at 9:26 AM
finance.yahoo.com logoLandos Biopharma Provides Company Update and Reports Third Quarter 2023 Results
finance.yahoo.com - November 9 at 9:26 AM
finance.yahoo.com logoLandos Biopharma Provides Company Update and Reports Third Quarter 2023 Results
finance.yahoo.com - November 9 at 9:26 AM
marketbeat.com logo
marketbeat.com - November 1 at 9:51 AM
finance.yahoo.com logoLandos Biopharma to Present at the American College of Gastroenterology 2023 Annual Scientific Meeting
finance.yahoo.com - October 23 at 8:43 AM
markets.businessinsider.com logoJonesTrading Sticks to Its Hold Rating for Landos Biopharma (LABP)
markets.businessinsider.com - September 22 at 8:26 PM
finance.yahoo.com logoLandos Biopharma to Present New Data on NX-13 from Phase 1b Trial in Ulcerative Colitis at United European Gastroenterology (UEG) Week 2023 Congress
finance.yahoo.com - September 19 at 8:34 AM
finance.yahoo.com logoLandos Biopharma to Present New Data on NX-13 from Phase 1b Trial in Ulcerative Colitis at United European Gastroenterology (UEG) Week 2023 Congress
finance.yahoo.com - September 19 at 8:34 AM
finance.yahoo.com logoLandos Biopharma Announces Strategic Research Collaboration with KU Leuven and University Hospitals Leuven to Further Characterize the Effects of NX-13 on Epithelial Cells
finance.yahoo.com - September 14 at 9:04 AM
finanznachrichten.de logoLandos Biopharma, Inc.: Landos Biopharma Provides Business Update & Reports Second Quarter 2023 Results
finanznachrichten.de - August 9 at 5:31 PM
seekingalpha.com logoSCPS Scopus BioPharma Inc.
seekingalpha.com - August 9 at 12:30 PM
finance.yahoo.com logoLandos Biopharma Provides Business Update & Reports Second Quarter 2023 Results
finance.yahoo.com - August 9 at 12:30 PM
finance.yahoo.com logoLandos Biopharma Provides Business Update & Reports Second Quarter 2023 Results
finance.yahoo.com - August 9 at 12:30 PM
finance.yahoo.com logoLandos Biopharma to Present at the 2023 Jefferies Healthcare Conference
finance.yahoo.com - May 31 at 8:09 PM
finanznachrichten.de logoLandos Biopharma, Inc.: Landos Biopharma Announces 1-for-10 Reverse Stock Split
finanznachrichten.de - May 26 at 11:19 AM
msn.com logoLandos Biopharma implements 1-for-10 reverse stock split to regain compliance with Nasdaq requirements
msn.com - May 25 at 8:26 PM
finance.yahoo.com logoLandos Biopharma Announces 1-for-10 Reverse Stock Split
finance.yahoo.com - May 25 at 8:26 PM
seekingalpha.com logoLABP Landos Biopharma, Inc.
seekingalpha.com - May 16 at 3:52 PM
Get Landos Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABP and its competitors with MarketBeat's FREE daily newsletter.

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

LABP Media Mentions By Week

LABP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LABP
News Sentiment

0.37

0.49

Average
Medical
News Sentiment

LABP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LABP Articles
This Week

2

1

LABP Articles
Average Week

Get Landos Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LABP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners